Kent E. Pryor

681 total citations
7 papers, 153 citations indexed

About

Kent E. Pryor is a scholar working on Hematology, Epidemiology and Molecular Biology. According to data from OpenAlex, Kent E. Pryor has authored 7 papers receiving a total of 153 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Hematology, 3 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Kent E. Pryor's work include Blood Coagulation and Thrombosis Mechanisms (4 papers), Acute Ischemic Stroke Management (3 papers) and Chemical Synthesis and Analysis (2 papers). Kent E. Pryor is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (4 papers), Acute Ischemic Stroke Management (3 papers) and Chemical Synthesis and Analysis (2 papers). Kent E. Pryor collaborates with scholars based in United States and Switzerland. Kent E. Pryor's co-authors include John H. Griffin, Berislav V. Zloković, Thomas P. Davis, Patrick D. Lyden, Howard Levy, Patricia D. Williams, William G. Kramer, Pooja Khatri, Zhijun Wang and Jeffrey L. Saver and has published in prestigious journals such as Stroke, Current Pharmaceutical Design and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Kent E. Pryor

7 papers receiving 150 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kent E. Pryor United States	5	72	44	43	32	21	7	153
Anamika Giri India	8	21 0.3×	17 0.4×	78 1.8×	40 1.3×	6 0.3×	22	211
Ivana Spiga Italy	7	16 0.2×	30 0.7×	94 2.2×	13 0.4×	9 0.4×	10	163
Asif Paker United States	5	9 0.1×	18 0.4×	116 2.7×	18 0.6×	13 0.6×	9	193
Xunyi Luo United States	7	22 0.3×	12 0.3×	68 1.6×	5 0.2×	5 0.2×	8	162
Bykova Ov Russia	6	51 0.7×	7 0.2×	43 1.0×	13 0.4×	2 0.1×	29	242
Narendra Siddaiah United States	4	54 0.8×	57 1.3×	22 0.5×	17 0.5×	33 1.6×	5	193
Eric Perkey United States	9	36 0.5×	57 1.3×	91 2.1×	23 0.7×	14 0.7×	14	260
Alessandro Maglione Italy	9	23 0.3×	12 0.3×	85 2.0×	7 0.2×	16 0.8×	16	172
José Vicente Hervás Spain	9	14 0.2×	8 0.2×	85 2.0×	24 0.8×	4 0.2×	20	220
Marian Girgis Egypt	10	23 0.3×	13 0.3×	95 2.2×	4 0.1×	6 0.3×	27	246

Countries citing papers authored by Kent E. Pryor

Since Specialization

Citations

This map shows the geographic impact of Kent E. Pryor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kent E. Pryor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kent E. Pryor more than expected).

Fields of papers citing papers by Kent E. Pryor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kent E. Pryor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kent E. Pryor. The network helps show where Kent E. Pryor may publish in the future.

Co-authorship network of co-authors of Kent E. Pryor

This figure shows the co-authorship network connecting the top 25 collaborators of Kent E. Pryor. A scholar is included among the top collaborators of Kent E. Pryor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kent E. Pryor. Kent E. Pryor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Lyden, Patrick D., Kent E. Pryor, Thomas P. Davis, et al.. (2021). Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation. Frontiers in Neurology. 12. 593582–593582. 12 indexed citations

2.

Lyden, Patrick D., José A. Fernández, Thomas P. Davis, et al.. (2020). 3K3A-Activated Protein C Variant Does Not Interfere With the Plasma Clot Lysis Activity of Tenecteplase. Stroke. 51(7). 2236–2239. 2 indexed citations

3.

Lyden, Patrick D., Christopher S. Coffey, Merit Cudkowicz, et al.. (2016). Selecting Patients for Intra-Arterial Therapy in the Context of a Clinical Trial for Neuroprotection. Stroke. 47(12). 2979–2985. 16 indexed citations

4.

Lyden, Patrick D., Howard Levy, Kent E. Pryor, et al.. (2014). Phase 1 Safety, Tolerability and Pharmacokinetics of 3K3A-APC in Healthy Adult Volunteers. Current Pharmaceutical Design. 19(42). 7479–7485. 56 indexed citations

5.

Williams, Patricia D., Berislav V. Zloković, John H. Griffin, Kent E. Pryor, & Thomas P. Davis. (2012). Preclinical Safety and Pharmacokinetic Profile of 3K3A-APC, a Novel, Modified Activated Protein C for Ischemic Stroke. Current Pharmaceutical Design. 18(27). 4215–4222. 45 indexed citations

6.

Kessler, Linda, Jeff Kucharski, Jan O. Lundström, et al.. (2008). 2,5-Diaminopyrimidines and 3,5-disubstituted azapurines as inhibitors of glycogen synthase kinase-3 (GSK-3). Bioorganic & Medicinal Chemistry Letters. 18(12). 3578–3581. 20 indexed citations

7.

Pryor, Kent E., et al.. (1999). A rapid method to identify exo-protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 9(16). 2291–2296. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact